Mind Medicine (MindMed) (MNMD) News Today $7.44 +0.33 (+4.64%) (As of 12/6/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Down 3% - What's Next?Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Down 3% - Time to Sell?November 29, 2024 | marketbeat.comAlly Bridge Group NY LLC Sells 176,918 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)Ally Bridge Group NY LLC lowered its holdings in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) by 18.3% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 788,508 shares of the company's stock after sellingNovember 28, 2024 | marketbeat.comQ3 EPS Estimate for Mind Medicine (MindMed) Cut by AnalystMind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) - Equities researchers at Roth Capital lowered their Q3 2025 earnings estimates for shares of Mind Medicine (MindMed) in a report issued on Tuesday, November 19th. Roth Capital analyst J. Wittes now forecasts that the company will earn ($0.November 22, 2024 | marketbeat.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Average Rating of "Buy" from AnalystsShares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) have been assigned a consensus rating of "Buy" from the twelve ratings firms that are presently covering the stock, MarketBeat.com reports. Nine research analysts have rated the stock with a buy rating and three have given a strNovember 21, 2024 | marketbeat.comMindMed Appoints Gregg Pratt, Ph.D. as Chief Regulatory and Quality Assurance OfficerNovember 19, 2024 | finance.yahoo.comMind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Up - Here's What HappenedMind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Up - Here's WhyNovember 15, 2024 | marketbeat.comMind Medicine (MindMed) Sees Unusually High Options Volume (NASDAQ:MNMD)Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) was the target of unusually large options trading activity on Friday. Traders acquired 4,593 call options on the stock. This is an increase of approximately 180% compared to the typical daily volume of 1,638 call options.November 15, 2024 | marketbeat.comMind Medicine Set to Engage at Key Investor ConferencesNovember 14, 2024 | markets.businessinsider.comMindMed to Participate in Upcoming Investor ConferencesNovember 13, 2024 | businesswire.comMind Medicine (MindMed)'s (MNMD) Buy Rating Reiterated at HC WainwrightHC Wainwright reiterated a "buy" rating and issued a $55.00 price objective on shares of Mind Medicine (MindMed) in a research note on Monday.November 11, 2024 | marketbeat.comOptimistic Outlook for Mind Medicine Amidst Promising Phase 3 Developments and Robust Financial HealthNovember 11, 2024 | markets.businessinsider.comMind Medicine: No News = Good NewsNovember 10, 2024 | seekingalpha.comMind Medicine’s Promising Potential and Financial Strength Justify Buy RatingNovember 10, 2024 | markets.businessinsider.comRBC Capital Keeps Their Buy Rating on Mind Medicine (MNMD)November 9, 2024 | markets.businessinsider.comMindMed Advances Phase 3 Trials in Mental HealthNovember 9, 2024 | markets.businessinsider.comMind Medicine (MindMed) Inc. (MNMD) Q3 2024 Earnings Call TranscriptNovember 8, 2024 | seekingalpha.comMindMed Reports Third Quarter 2024 Financial Results and Business UpdatesNovember 7, 2024 | finance.yahoo.comMind Medicine (MindMed) Inc. 2024 Q3 - Results - Earnings Call PresentationNovember 7, 2024 | seekingalpha.comMind Medicine (MindMed) (NASDAQ:MNMD) Shares Up 10.1% - What's Next?Mind Medicine (MindMed) (NASDAQ:MNMD) Trading Up 10.1% - Time to Buy?November 7, 2024 | marketbeat.comMind Medicine (MindMed) (MNMD) Scheduled to Post Earnings on ThursdayMind Medicine (MindMed) (NASDAQ:MNMD) will be releasing earnings after the market closes on Thursday, November 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=639533)October 31, 2024 | marketbeat.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Average Recommendation of "Buy" from BrokeragesShares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) have been assigned a consensus recommendation of "Buy" from the twelve brokerages that are currently covering the firm, MarketBeat.com reports. Nine research analysts have rated the stock with a buy rating and three have issuedOctober 27, 2024 | marketbeat.comMindMed to Host Conference Call and Webcast to Discuss Third Quarter 2024 Financial Results and Provide Business UpdateOctober 24, 2024 | finance.yahoo.comMind Medicine (MindMed) (NASDAQ:MNMD) Raised to "Strong-Buy" at Leerink PartnrsLeerink Partnrs upgraded Mind Medicine (MindMed) to a "strong-buy" rating in a research report on Friday.October 15, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Coverage Initiated at Leerink PartnersLeerink Partners started coverage on shares of Mind Medicine (MindMed) in a research note on Monday. They issued an "outperform" rating and a $20.00 price objective on the stock.October 14, 2024 | marketbeat.comMind Medicine assumed with an Outperform at LeerinkOctober 13, 2024 | finance.yahoo.comMind Medicine (NASDAQ:MNMD) Stock, Short Interest ReportOctober 6, 2024 | benzinga.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Consensus Recommendation of "Buy" from BrokeragesShares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) have received an average rating of "Buy" from the twelve ratings firms that are currently covering the company, MarketBeat Ratings reports. Ten investment analysts have rated the stock with a buy recommendation and two have assiOctober 2, 2024 | marketbeat.comMarshall Wace LLP Grows Holdings in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)Marshall Wace LLP lifted its holdings in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) by 8.1% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,160,203 shares of the company's stock after buying an additional 161,659 shares duringSeptember 28, 2024 | marketbeat.comCarrie Liao Sells 2,352 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) StockSeptember 26, 2024 | insidertrades.comRhumbline Advisers Invests $679,000 in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)Rhumbline Advisers purchased a new stake in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 94,116 shares of the company's stock, valued at approximateSeptember 25, 2024 | marketbeat.comGritstone bio, Inc. (2JQ.F) Stock Price, News, Quote & History - Yahoo FinanceSeptember 23, 2024 | finance.yahoo.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Shares Bought by Bank of New York Mellon CorpBank of New York Mellon Corp lifted its position in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) by 472.7% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 246,208 shares of the company's stock after buying aSeptember 19, 2024 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) PT Lowered to $14.00 at Canaccord Genuity GroupCanaccord Genuity Group cut their target price on Mind Medicine (MindMed) from $16.00 to $14.00 and set a "buy" rating on the stock in a research note on Monday.September 16, 2024 | marketbeat.comMindMed Announces New Employee Inducement GrantsSeptember 11, 2024 | finance.yahoo.comQ3 2024 Earnings Forecast for Mind Medicine (MindMed) Inc. Issued By HC Wainwright (NASDAQ:MNMD)Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) - Equities research analysts at HC Wainwright boosted their Q3 2024 earnings per share (EPS) estimates for shares of Mind Medicine (MindMed) in a note issued to investors on Thursday, August 29th. HC Wainwright analyst P. Trucchio now expecSeptember 2, 2024 | marketbeat.comMind Medicine Inc (MMQ.DU)August 29, 2024 | sg.finance.yahoo.comMind Medicine (MindMed) (NASDAQ:MNMD) Price Target Raised to $55.00 at HC WainwrightHC Wainwright lifted their target price on shares of Mind Medicine (MindMed) from $35.00 to $55.00 and gave the stock a "buy" rating in a report on Thursday.August 29, 2024 | marketbeat.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Director David W. Gryska Acquires 3,500 SharesAugust 27, 2024 | insidertrades.comQ3 2024 Earnings Estimate for Mind Medicine (MindMed) Inc. Issued By Leerink Partnrs (NASDAQ:MNMD)Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) - Equities research analysts at Leerink Partnrs increased their Q3 2024 earnings per share (EPS) estimates for Mind Medicine (MindMed) in a research note issued on Tuesday, August 13th. Leerink Partnrs analyst R. Li now forecasts that the cAugust 16, 2024 | marketbeat.comMindMed Reports Second Quarter 2024 Financial Results and Business UpdatesAugust 14, 2024 | finance.yahoo.comSmall Cap Stocks: Mind Medicine (MNMD) Is a Psychedelic Biotechnology BetAugust 14, 2024 | msn.comMind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Up to $6.85Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Up to $6.85August 13, 2024 | marketbeat.comPacific Defense Announces US Army CMFF Program TeamAugust 13, 2024 | businesswire.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Consensus Rating of "Buy" from AnalystsMind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) has earned an average recommendation of "Buy" from the eleven brokerages that are currently covering the stock, Marketbeat reports. Nine analysts have rated the stock with a buy rating and two have issued a strong buy rating on the compAugust 13, 2024 | marketbeat.comMindMed And Other Psychedelic Stocks Brace For FDA's Decision On MDMA TherapyAugust 7, 2024 | seekingalpha.comMind Medicine (MindMed) (MNMD) Set to Announce Earnings on TuesdayMind Medicine (MindMed) (NASDAQ:MNMD) will be releasing earnings before the market opens on Tuesday, August 13, Zacks reports.August 7, 2024 | marketbeat.comMindMed to Present at Canaccord Genuity’s 44th Annual Growth ConferenceAugust 6, 2024 | finance.yahoo.comMindMed to Host Conference Call and Webcast to Discuss Second Quarter 2024 Financial Results and Provide Business UpdateAugust 6, 2024 | finance.yahoo.comMind Medicine (MindMed) (NASDAQ:MNMD) Trading Down 11.1%Mind Medicine (MindMed) (NASDAQ:MNMD) Trading Down 11.1%August 5, 2024 | marketbeat.comTidal Investments LLC Invests $1.70 Million in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)Tidal Investments LLC acquired a new stake in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) during the first quarter, according to its most recent filing with the SEC. The firm acquired 180,600 shares of the company's stock, valued at approximately $1,698,000. Tidal Investments LLC ownedAugust 3, 2024 | marketbeat.com Get Mind Medicine (MindMed) News Delivered to You Automatically Sign up to receive the latest news and ratings for MNMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Radical change could be coming — do this NOW to protect yourself (Ad)Legendary financial forecaster, Dr. Martin Weiss has recently uncovered what could be the Deep State's chilling plan to radically change America forever. It involves the Fed … Artificial Intelligence … And a Draconian set of laws that could install total financial surveillance … Click here to learn more. MNMD Media Mentions By Week MNMD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MNMD News Sentiment▼0.000.69▲Average Medical News Sentiment MNMD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MNMD Articles This Week▼03▲MNMD Articles Average Week Get Mind Medicine (MindMed) News Delivered to You Automatically Sign up to receive the latest news and ratings for MNMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TLRY News CRON News USNA News CDXC News CGC News BTMD News SNDL News ACB News MDWD News FTLF News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MNMD) was last updated on 12/8/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredUrgent warning about your moneyThe stock market is booming … And Bitcoin just hiked through the roof. But don't get fooled by the "good...Weiss Ratings | SponsoredElon declares war on company he co-founded!?Elon Musk is leading humanity into the new era of AI. He’s just received a fresh $6 billion in funding for ...Porter & Company | SponsoredWall Street genius says this bubble has run its course – what to doWhile the media is telling you to be excited about the stock market, Wall Street and the market's top experts ...Stansberry Research | SponsoredIs the US economic collapse finally here?Something unsettling is happening to the U.S. economy right now... And it could spell disaster for millions...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mind Medicine (MindMed) Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mind Medicine (MindMed) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MNMD Stock Alerts